Management wants to sell Lympro for a decent price, i.e. at least 800 million which is it what Eli Lilly paid for Amyvid. At least that's my opinion. You guys are talking about lympro sales twelve months from now? Pfffft, they could sell lympro to the highest bidder in 6 months or less -- maybe much sooner -- for enough cash to put us on a major exchange without the need for a RS despite what Mr. Napodano is saying now about the necessity of a reverse split on twitter. IMHO.